Annual congress focused on vaccines and immunotherapeutics
Official title: ISV - International Society for Vaccines 2024 Annual Congress
Funded at International Society of Vaccines · NIH-11000717 · Data updated 2026-11-12
This study is all about a big meeting where scientists from around the world come together to share new ideas and discoveries about vaccines that can help prevent and treat diseases, including cancer, and it's a great chance for new researchers to connect and learn from each other.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International Society of Vaccines NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project start | July 19, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $7,000 |
| NIH project number | 1R13AI186468-01 |
| Project ID | NIH-11000717 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include researchers, healthcare professionals, and students interested in vaccine science and immunotherapy.
✕Less likely to help
Patients who are not involved in vaccine research or do not have a professional interest in immunotherapeutics may not benefit from this congress.
What this research studies
The International Society for Vaccines hosts an annual congress that brings together researchers from around the world to discuss the latest advancements in vaccines and immunotherapeutics. This event features presentations on both prophylactic and therapeutic vaccines for infectious and chronic diseases, including cancer. Participants can engage in discussions about basic research, manufacturing processes, and clinical trials, with opportunities for networking and mentorship, especially for early career researchers and those from underrepresented backgrounds. The congress aims to foster collaboration and knowledge sharing among scientists globally.
Why it matters
Potential benefit: If successful, this congress could lead to significant advancements in vaccine development and implementation, ultimately improving public health outcomes.
How similar studies have gone: Previous congresses have successfully facilitated collaboration and innovation in vaccine research, indicating a strong potential for impactful outcomes.
Where this research is happening
-
International Society of Vaccines
Worcester, United States Active
Researchers
- Principal investigator: Weiner, David B. — International Society of Vaccines
- Study coordinator: Weiner, David B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.